InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,713.64
(
1.70%
)
US TECH 100
19,314.40
(
2.42%
)
Dow Jones
42,025.19
(
1.26%
)
Brent Oil
74.32
(
2.68%
)
Bitcoin
62,965.59
(
2.10%
)
Post# of 648882
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

dDT

Send PM Follow Ignore
Followers 470
Posts 76416
Boards Moderated 3
Alias Born 03/31/2008

dDT

Re: None

Monday, 01/26/2015 9:30:31 AM

Monday, January 26, 2015 9:30:31 AM

Post# of 648882
Brainstorm up on preclinical results

Giddy traders propel nano cap Brainstorm Cell Therapeutics (NASDAQ:BCLI) up 11% premarket on robust volume in response to its announcement of positive preclinical results for NurOwn cells in the BTBR mouse model of autism. Treatment with NurOwn demonstrated marked behavioral benefits in BTBR mice after a single treatment. The results are encouraging but a colossal amount of development work lies ahead to validate the efficacy of NurOwn in humans for this indication.
NurOwn cells are mesenchymal stem cells that have been induced, via the company's proprietary methods, to secrete a variety of neurotrophic factors.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up